Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palisade-1: PH94B in Social Anxiety Disorder
NCT04754802Phase 3Completed
- Sponsor
- Vistagen Therapeutics
- Start
- May 2021
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fasedienol in Social Anxiety Disorder (SAD), sponsored by Vistagen Therapeutics. Started May 2021; status: completed.
02
Drugs
fasedienol
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT04754802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04754802.